Market closed · Next open: Monday 9:30 AM ET
Last update: Aug 28, 2026, 6:10 PM ET
Thermo Fisher Scientific Inc.
$622.18 1.35% today
Market Closed

Why Thermo Fisher Scientific Inc. (TMO) stock moved

Updated Aug 30, 2026

Thermo Fisher Scientific Inc. (TMO) shares fell 1.4% to $622.18 as of August 30, 2026, a modest decline from the prior close of $630.70. BestStocks flagged the session as a major change for TMO. Below, we break down what changed for TMO, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

TMO fell 1.4% to $622.18

TMO fell 1.4% in its latest session, moving from $630.70 to $622.18.

ValuationCompany-Specific MoveWeak confidence
Rel. volume
0.5×
Below Avg
Vs peers
Top 7 of 7 peers
Underperforming
Market cap
$231.2B
New York Stock Exchange
Analyst target
$598
-3.9% vs price
Price chart
Jul 30 – Aug 28
VVFNNENV$564$599$635Jul 30Aug 6Aug 14Aug 21Aug 28
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Thermo Fisher Scientific Inc. investors

For Thermo Fisher Scientific Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Thermo Fisher Scientific surged +4.39% to $614.90 following a wave of major institutional 13F filings showing significant new and increased stakes in the life sciences company; Thermo Fisher Scientific Inc. (TMO) moved +2.86% from $510.13 to $524.71 on 2026-07-09, reaching a new 30-day high. Weighing against that: Negative session, down 1.4%; New SEC filing — review for material disclosures. Because the move outpaced peers, it looks driven by TMO-specific developments rather than a broad sector rotation. Wall Street's consensus price target sits at $597.67, implying -3.9% downside from $622.18. Over the past 90 days analysts logged 0 upgrades and 1 downgrade. BestStocks rates the overall signal quality weak (36/100). With earnings roughly 59 days out, the next report is the most likely near-term test of the move.

TMO price reaction

TMO last traded at $622.18, down $8.52 (-1.35%) from the previous close of $630.70. The session traded on 0.5× average volume (below avg), so participation was unremarkable. Its healthcare peer group moved a median -0.3% over the same stretch, leaving TMO behind the group by 1.1 points. Over the past month the stock has ranged between $564.75 and $633.71, and it currently sits about 83% of the way up that band.

Bullish and bearish analyst opinions on Thermo Fisher Scientific Inc. (TMO)

The consensus analyst price target on Thermo Fisher Scientific Inc. (TMO) is $597.67, 3.9% below the recent $622.18. Over the past 90 days analysts logged 0 upgrades, 5 maintains, and 1 downgrade. Here is how the bullish and bearish cases on TMO line up.

The bullish case

  • The Street's most bullish target is $650.00 (+4.5%).
  • Thermo Fisher Scientific surged +4.39% to $614.90 following a wave of major institutional 13F filings showing significant new and increased stakes in the life sciences company.
  • Positive price momentum.

The bearish case

  • The consensus analyst price target of $597.67 sits 3.9% below the recent $622.18, so the average target sees limited room to run.
  • The most bearish analyst target is $520.00 (-16.4%).
  • 1 analyst downgrade in the past 90 days, most recently HSBC to Hold (2026-06-03).
  • Negative session, down 1.4%.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Aug 30, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $598-3.9%
= 5 maintains1 downgrades
Morgan Stanley maintained Overweight · 2026-07-27
SEC filings watch
10-Q2026-07-31
Quarterly financial results
medium
8-K2026-07-23
Material event — review for impact
high
8-K2026-05-26
Material event — review for impact
high
Peer context
TMO-1.4%
LLY-0.3%
UNH-0.5%
JNJ+0.9%
PFE-0.2%
ABBV-1.0%

Previous notable changes for TMO

News2026-08-24-0.1%
DCF valuation analysis values TMO at $491 per share amid 30.6% year-to-date stock appreciation.
News2026-08-22
Avanda Investment Management acquired 4,000 TMO shares ($2 million position) in Q2.
Activity2026-08-19+4.2%via in.investing.com
Thermo Fisher Scientific surged +4.39% to $614.90 following a wave of major institutional 13F filings showing significant new and increased stakes in the life sciences company. BlackRock disclosed a position of 30.9 million shares (~$15.5B), while Deutsche Bank and other institutional managers revealed substantial new multi-million dollar purchases during Q2 (per ir.thermofisher.com and in.investing.com). The buying interest follows strong Q2 earnings that beat consensus ($11.99B revenue) with raised guidance, plus the recent $1.1B sale of the microbiology unit that clarified capital deployment options. Volume stands at 697,667 shares (1.05x normal for this stage of session).
News2026-08-10+1.0%
TMO reported Q2 2026 revenue growth of 10% to $11.99B with adjusted EPS rising 13% to $6.03.

In-depth TMO event analyses

Permanent, dated analyses of TMO's most significant sessions.
Upcoming catalysts & outlook
Next earnings
2026-10-28 (est.)
in 59 days
10-Q Filing (est.)
2026-10-30
Medium impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
Low
from change events

Frequently asked questions about TMO

Why did Thermo Fisher Scientific Inc. (TMO) stock move?

TMO fell 1.4% to $622.18. No single company-specific catalyst was confirmed during the move window, and it looks like a company-specific move.

How much did TMO stock fall?

TMO lost 1.35% ($8.52) versus the prior close of $630.70, last trading at $622.18 on 0.5× average volume.

When is Thermo Fisher Scientific Inc.'s next earnings date?

TMO's next earnings report is estimated for 2026-10-28 — about 59 days away.

What is the analyst price target for TMO?

The consensus analyst price target for TMO is $597.67, about 3.9% below the current $622.18. Over the past 90 days, analysts recorded 0 upgrades, 5 maintains, and 1 downgrade.

Is the TMO move company-specific or sector-wide?

BestStocks classifies it as a company-specific move: the peer group moved a median -0.3% against TMO's -1.4%. TMO ranks top 7 of 7 peers.

How BestStocks tracks TMO

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared TMO-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for TMO, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 30, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.